PRNP129 | Healthy controls (n = 189) | Sporadic CJD patients (n = 180) | P-value1 | P-value2 | ||||
---|---|---|---|---|---|---|---|---|
 | MM (n = 180) | MV (n = 9) | VV (n = 0) | MM (n = 180) | MV (n = 0) | VV (n = 0) |  |  |
Genotype frequency, n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
TT | 84 (46.7) | 7 (7.8) | - | 87 (48.3) | - | - | Â | Â |
TC | 75 (41.7) | 2 (2.2) | - | 78 (43.3) | - | - | 0.233 | 0.570 |
CC | 21 (11.6) | 0 (0) | - | 15 (8.3) | - | - | Â | Â |
Allele frequency | Â | Â | Â | Â | Â | Â | Â | Â |
T | 0.68 | 0.89 | - | 0.70 | - | - | 0.057 | 0.469 |
C | 0.32 | 0.11 | - | 0.30 | - | - | Â | Â |
PRNP 219 | Healthy controls (n = 189) | Sporadic CJD patients (n = 180) | P- value 3 | P- value 4 | ||||
 | EE (n = 173) | EK (n = 16) | KK (n = 0) | EE (n = 180) | EK (n = 0) | KK (n = 0) |  |  |
Genotype frequency, n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
TT | 86 (49.7) | 5 (31.3) | - | 87 (48.3) | - | - | Â | Â |
TC | 68 (39.3) | 9 (56.3) | - | 78 (43.3) | - | - | 0.338 | 0.600 |
CC | 19 (11.0) | 2 (12.4) | - | 15 (8.3) | - | - | Â | Â |
Allele frequency | Â | Â | Â | Â | Â | Â | Â | Â |
T | 0.69 | 0.59 | - | 0.70 | - | - | 0.244 | 0.854 |
C | 0.31 | 0.41 | - | 0.30 | - | - | Â | Â |